Search Results - helen+dooley

1 Results Sort By:
Multispecific Antibodies that Induce Downregulation of Programmed Death-ligand 1
Unmet Need: It is estimated that in 2018 there were more than 17 million new cases of cancer worldwide (see ACS). Immune checkpoint therapies have become a powerful treatment route for a wide variety of cancer types and have increased the life expectancy for patients whose disease is refractory to all other therapies. Due to variability in patient response...
Published: 3/14/2025   |   Inventor(s): Jamie Spangler, Seth Ludwig, Angela Zhu, Rakeeb Kureshi, Helen Dooley
Keywords(s):  
Category(s): Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Antibodies
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum